Drugs / human polyclonal rabies immune globulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01228383 Comparator | Dec 2011 → Oct 2012 | rabies | Crucell Holland BV | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human polyclonal rabies immune globulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01228383 ↗ |
| Known as | HRIG | “human polyclonal rabies immune globulin (HRIG)” NCT01228383 ↗ |
| Modality | Protein / enzyme biologic | “human polyclonal rabies immune globulin (HRIG)” NCT01228383 ↗ |
| Route | Intramuscular | “HRIG 20 IU/kg intramuscularly on Day 0.” NCT01228383 ↗ |